CardioGenics Holdings, Inc. (OTCC:CGNH) announced that the completion of the acquisition by JAG Media Holdings, Inc on Friday, July 31, 2009. ExchangeCo acquired outstanding CardioGenics common stock, except for 173,869 common shares owned by two minority stockholders of CardioGenics. CardioGenics stockholders received 422,183,610 shares of JAG Media common stock.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
CardioGenics Holdings Inc develops technology and products focused on the immunoassay segment of the in-vitro diagnostic testing market through its subsidiaries. The company developed the QL Care Analyzer which will run numerous diagnostic tests under development, the first series being cardiovascular diagnostic tests. CardioGenics was acquired by EschangeCo, Inc, in July 2009.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Us
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
